Commodore Capital Lp Top Holdings and 13F Report (2024) About Commodore Capital LpInvestment ActivityCommodore Capital Lp has $1.42 billion in total holdings as of June 30, 2024.Commodore Capital Lp owns shares of 33 different stocks, but just 16 companies or ETFs make up 80% of its holdings.Approximately 23.16% of the portfolio was purchased this quarter.About 25.25% of the portfolio was sold this quarter.This quarter, Commodore Capital Lp has purchased 31 new stocks and bought additional shares in 10 stocks.Commodore Capital Lp sold shares of 8 stocks and completely divested from 5 stocks this quarter.Largest Holdings Merus $185,415,000Nuvalent $104,912,500Xenon Pharmaceuticals $94,682,500Enliven Therapeutics $94,137,749Agios Pharmaceuticals $77,329,500 Largest New Holdings this Quarter 74366E102 - Protagonist Therapeutics $59,415,250 Holding171757206 - CIDARA THERAPEUTICS INC $57,234,250 Holding75943R102 - Relay Therapeutics $46,191,000 Holding501575104 - Kymera Therapeutics $32,730,000 Holding23284F105 - CytomX Therapeutics $17,461,521 Holding Largest Purchases this Quarter Protagonist Therapeutics 1,075,000 shares (about $59.42M)CIDARA THERAPEUTICS INC 1,175,000 shares (about $57.23M)Relay Therapeutics 13,350,000 shares (about $46.19M)Kymera Therapeutics 750,000 shares (about $32.73M)Xenon Pharmaceuticals 700,000 shares (about $21.91M) Largest Sales this Quarter Merus 947,840 shares (about $49.86M)Cogent Biosciences 6,581,652 shares (about $47.26M)Soleno Therapeutics 540,000 shares (about $45.24M)Vera Therapeutics 1,761,782 shares (about $41.51M)Nuvalent 480,000 shares (about $36.62M) Sector Allocation Over TimeMap of 500 Largest Holdings ofCommodore Capital Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorMRUSMerus$185,415,000$49,856,384 ▼-21.2%3,525,00013.1%MedicalNUVLNuvalent$104,912,500$36,624,000 ▼-25.9%1,375,0007.4%MedicalXENEXenon Pharmaceuticals$94,682,500$21,910,000 ▲30.1%3,025,0006.7%MedicalELVNEnliven Therapeutics$94,137,749$357,249 ▲0.4%4,692,8096.6%MedicalAGIOAgios Pharmaceuticals$77,329,500$4,656,400 ▲6.4%2,325,0005.5%MedicalCLDXCelldex Therapeutics$70,207,500$5,087,500 ▲7.8%3,450,0005.0%MedicalALKSAlkermes$70,094,500$14,305,000 ▲25.6%2,450,0004.9%MedicalVRDNViridian Therapeutics$68,152,500$17,824,500 ▲35.4%4,875,0004.8%MedicalPTGXProtagonist Therapeutics$59,415,250$59,415,250 ▲New Holding1,075,0004.2%MedicalCIDARA THERAPEUTICS INC$57,234,250$57,234,250 ▲New Holding1,175,0004.0%COM NEWSRRKScholar Rock$51,359,000$10,448,900 ▼-16.9%1,450,0003.6%MedicalSLNOSoleno Therapeutics$51,105,800$45,241,200 ▼-47.0%610,0003.6%MedicalRLAYRelay Therapeutics$46,191,000$46,191,000 ▲New Holding13,350,0003.3%MedicalNRIXNurix Therapeutics$44,975,158$344,593 ▼-0.8%3,948,6533.2%MedicalCNTACentessa Pharmaceuticals$43,339,517$12,229,542 ▲39.3%3,298,2893.1%MedicalPHVSPharvaris$33,641,2210.0%1,911,4332.4%MedicalKYMRKymera Therapeutics$32,730,000$32,730,000 ▲New Holding750,0002.3%MedicalMNMDMind Medicine (MindMed)$32,450,000$3,082,750 ▲10.5%5,000,0002.3%MedicalSPYRE THERAPEUTICS INC$29,761,6170.0%1,988,0842.1%COM NEWTYRATyra Biosciences$29,667,000$20,575,500 ▲226.3%3,100,0002.1%MedicalVERAVera Therapeutics$18,848,000$41,507,584 ▼-68.8%800,0001.3%MedicalCTMXCytomX Therapeutics$17,461,521$17,461,521 ▲New Holding7,692,3001.2%MedicalCOGTCogent Biosciences$16,594,158$47,256,263 ▼-74.0%2,311,1641.2%MedicalORUKA THERAPEUTICS INC$15,914,9940.0%1,419,7141.1%COMBRIGHT MINDS BIOSCIENCES INC$13,055,0000.0%500,0000.9%COM NEWAPOGEE THERAPEUTICS INC$12,594,7000.0%290,0000.9%COMIKTInhibikase Therapeutics$10,525,102$103,459 ▲1.0%5,397,4880.7%MedicalPERCEPTIVE CAP SOLUTIONS COR$7,965,0000.0%750,0000.6%CL A ORD SHSTNGXTango Therapeutics$7,680,000$7,680,000 ▲New Holding1,500,0000.5%MedicalCRESCENT BIOPHARMA INC.$7,322,492$7,322,492 ▲New Holding453,6860.5%COMNEUROGENE INC$6,396,597$7,432,154 ▼-53.7%427,8660.5%COMVTGNVistaGen Therapeutics$3,150,0000.0%1,575,0000.2%MedicalAVALO THERAPEUTICS INC$2,410,1700.0%483,0000.2%COM NEWPCVXVaxcyte$0$62,304,000 ▼-100.0%00.0%MedicalSLDBSolid Biosciences$0$21,552,500 ▼-100.0%00.0%MedicalCRDFCardiff Oncology$0$16,907,694 ▼-100.0%00.0%MedicalORICOric Pharmaceuticals$0$11,160,000 ▼-100.0%00.0%MedicalCELCCelcuity$0$7,033,022 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access